Corrigendum to "Cross-sectional analysis of students and school workers reveals a high number of asymptomatic SARS-CoV-2 infections during school reopening in Brazilian cities" [Heliyon 8 (11) (November 2022) Article e11368].

Autor: Borges LP; Department of Pharmacy, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil., Guimarães AG; Department of Pharmacy, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil., Fonseca DLM; Interunit Postgraduate Program on Bioinformatics, Institute of Mathematics and Statistics (IME), University of Sao Paulo (USP), Sao Paulo, SP, Brazil., Freire PP; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil., Barreto ÍDC; Nuclear and Energy Technology Graduate Program (UFPE), Recife, Pernambuco, Brazil., Souza DRV; Department of Education in Health, Lagarto and Post-graduate Program in Health Sciences, Federal University of Sergipe, Sergipe, Brazil., Gurgel RQ; Department of Medicine and Post-Graduate Programs in Parasitic Biology and Health Sciences, Federal University of Sergipe, Aracaju, Sergipe, Brazil., Lopes ASA; Department of Education in Health, Lagarto and Post-graduate Program in Health Sciences, Federal University of Sergipe, Sergipe, Brazil., Melquiades de Rezende Neto J; Department of Education in Health, Lagarto and Post-graduate Program in Health Sciences, Federal University of Sergipe, Sergipe, Brazil., Dos Santos KA; Department of Pharmacy, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil., Matos ILS; Department of Pharmacy, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil., da Invenção GB; Department of Pharmacy, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil., Oliveira BM; Department of Pharmacy, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil., Santos AA; Department of Pharmacy, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil., Soares DA; Department of Pharmacy, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil., de Jesus PC; Department of Pharmacy, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil., Dos Santos CA; Sergipe Central Public Health Laboratory, Aracaju, Sergipe, Brazil., Goes MAO; Department of Medicine and Post-Graduate Programs in Parasitic Biology and Health Sciences, Federal University of Sergipe, Aracaju, Sergipe, Brazil.; State Health Department, Sergipe, Brazil., Plaça DR; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, Brazil., Filgueiras IS; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil., Marques AHC; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil., Baiocchi GC; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil., CabralMiranda W; The Sabará Children's Hospital and PENSI Institute, São Paulo, SP, Brazil., Cabral de Miranda G; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil., Saraiva Camara NO; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil., Garcia Calich VL; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil., Ramos RN; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-ImmunoHematology (LIM-31), Department of Hematology and Cell Therapy, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Instituto D'Or de Ensino e Pesquisa, São Paulo, Brazil., Nakaya HI; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, Brazil.; Hospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.; Scientific Platform Pasteur, University of São Paulo, São Paulo 05508-020, Brazil., Rocha V; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-ImmunoHematology (LIM-31), Department of Hematology and Cell Therapy, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Instituto D'Or de Ensino e Pesquisa, São Paulo, Brazil.; Fundação Pró-Sangue-Hemocentro de São Paulo, São Paulo, Brazil.; Churchill Hospital, Department of Hematology, University of Oxford, Oxford, United Kingdom., Giil LM; Department of Internal Medicine, Haraldsplass Deaconess Hospital, Bergen, Norway., Ochs HD; Department of Pediatrics, University of Washington School of Medicine, And Seattle Children's Research Institute; Seattle, WA, USA., Schimke LF; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil., de Souza MSF; Department of Medicine and Post-Graduate Programs in Parasitic Biology and Health Sciences, Federal University of Sergipe, Aracaju, Sergipe, Brazil.; State Health Department, Sergipe, Brazil., Cuevas LE; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Martins AF; Department of Education in Health, Lagarto and Post-graduate Program in Health Sciences, Federal University of Sergipe, Sergipe, Brazil., Cabral-Marques O; Interunit Postgraduate Program on Bioinformatics, Institute of Mathematics and Statistics (IME), University of Sao Paulo (USP), Sao Paulo, SP, Brazil.; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil.; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, Brazil.; Laboratory of Medical Investigation 29, University of São Paulo School of Medicine, Brazil.; Department of Pharmacy and Postgraduate Program of Health and Science, Federal University of Rio Grande do Norte, Natal, Brazil.

Publikováno v: Heliyon [Heliyon] 2023 Mar; Vol. 9 (3), pp. e14398. Date of Electronic Publication: 2023 Mar 15.